These findings suggest that thymidine phosphorylase deficiency leads to broader metabolic disturbances than previously recognized and supports the existence of an expanded biomarker profile for MNGIE. The gene discussed is TYMP; the disease is mitochondrial neurogastrointestinal encephalomyopathy.